NURS 6903 Advanced pharm - quiz 1 (Actual Exam 2025) |
Complete Questions and Correct Answers with
Rationales| Graded A+ | Verified Answers
Terms in this set (141)
What is an effect of adrenergic A. Inhibits norepinephrine release and
alpha-2 receptor site promotes vasodilation
stimulation?
A. Inhibits norepinephrine
release and promotes
vasodilation
B. Causes vasoconstriction
promoting increased blood
pressure
C. Increases in GI motility and tone
D. Increases urinary sphincter
contraction but relaxes
bladder neck
Cholinergic receptor sites, A. Muscarinic
primarily localized at smooth
muscle
neuromuscular junctions are called
__________ receptors.
A. Muscarinic
B. Nicotinic
C. Alpha
D. Beta
Anticholinergic Side Effects A. dry mouth
Include:
A. Dry mouth
B. Hypotension
C. Glaucoma
D. Increased bowel sounds
,A patient who has infrequent C. Ask the patient to keep a headache diary to
migraine headaches wants to help determine possible triggers.
prevent
them from occurring. What
intervention will the provider
take?
A. Prescribe prochlorperazine.
B. Prescribe amitriptyline.
C. Ask the patient to keep a
headache diary to help
determine possible triggers.
D. Schedule the abortive
medication to be taken
regularly
instead of PRN.
An infant is prescribed a C. Evidence of drug toxicity
medication that has a narrow
therapeutic
range and is excreted by the
kidneys. The provider will
monitor closely
for which effect?
A. Decreased drug effectiveness
B. Tachyphylaxis
C. Evidence of drug toxicity
D. Unusual CNS effects
8. An infant developed a B. Applying an antihistamine to the skin can cause toxicity
pruritic rash following
exposure to an allergen.
The infant's parents ask the
provider about using a topical
antihistamine. What information
should the provider use to
address the
parents' question?
A. Antihistamines given by this
route are not absorbed as
well in children.
B. Applying an antihistamine
,to the skin can cause toxicity
in this age group.
C. The child will also need oral
medication to achieve
effective results.
D.Topical medications have
fewer side effects than those
given by other routes
, A patient has taken a narcotic C. This patient has developed
analgesic for chronic pain for pharmacodynamic tolerance, which has
several increased the minimal effective
months. At a follow-up concentration (MEC) needed for analgesic
appointment, the provider notes effect.
that the
patient has been taking more than
the prescribed dosage. The
patient
has normal vital signs, is awake
and alert, and reports mild
pain. What
does the provider suspect is
responsible for the patient's
response?
A. This patient exhibits a
negative placebo effect with a
reduced response to
the drug. 2
B. This patient has
developed tachyphylaxis
because of
repeated exposure to the drug.
C. This patient has
developed
pharmacodynamic
tolerance,
which has increased the minimal
effective concentration
(MEC) needed for analgesic effect.
D.This patient has increased
hepatic enzyme
production as
a result of prolonged exposure to
the drug.
The CNP realizes that beta1 C. Increased myocardial contractility and heart rate
receptor stimulation leads
to which condition?
Complete Questions and Correct Answers with
Rationales| Graded A+ | Verified Answers
Terms in this set (141)
What is an effect of adrenergic A. Inhibits norepinephrine release and
alpha-2 receptor site promotes vasodilation
stimulation?
A. Inhibits norepinephrine
release and promotes
vasodilation
B. Causes vasoconstriction
promoting increased blood
pressure
C. Increases in GI motility and tone
D. Increases urinary sphincter
contraction but relaxes
bladder neck
Cholinergic receptor sites, A. Muscarinic
primarily localized at smooth
muscle
neuromuscular junctions are called
__________ receptors.
A. Muscarinic
B. Nicotinic
C. Alpha
D. Beta
Anticholinergic Side Effects A. dry mouth
Include:
A. Dry mouth
B. Hypotension
C. Glaucoma
D. Increased bowel sounds
,A patient who has infrequent C. Ask the patient to keep a headache diary to
migraine headaches wants to help determine possible triggers.
prevent
them from occurring. What
intervention will the provider
take?
A. Prescribe prochlorperazine.
B. Prescribe amitriptyline.
C. Ask the patient to keep a
headache diary to help
determine possible triggers.
D. Schedule the abortive
medication to be taken
regularly
instead of PRN.
An infant is prescribed a C. Evidence of drug toxicity
medication that has a narrow
therapeutic
range and is excreted by the
kidneys. The provider will
monitor closely
for which effect?
A. Decreased drug effectiveness
B. Tachyphylaxis
C. Evidence of drug toxicity
D. Unusual CNS effects
8. An infant developed a B. Applying an antihistamine to the skin can cause toxicity
pruritic rash following
exposure to an allergen.
The infant's parents ask the
provider about using a topical
antihistamine. What information
should the provider use to
address the
parents' question?
A. Antihistamines given by this
route are not absorbed as
well in children.
B. Applying an antihistamine
,to the skin can cause toxicity
in this age group.
C. The child will also need oral
medication to achieve
effective results.
D.Topical medications have
fewer side effects than those
given by other routes
, A patient has taken a narcotic C. This patient has developed
analgesic for chronic pain for pharmacodynamic tolerance, which has
several increased the minimal effective
months. At a follow-up concentration (MEC) needed for analgesic
appointment, the provider notes effect.
that the
patient has been taking more than
the prescribed dosage. The
patient
has normal vital signs, is awake
and alert, and reports mild
pain. What
does the provider suspect is
responsible for the patient's
response?
A. This patient exhibits a
negative placebo effect with a
reduced response to
the drug. 2
B. This patient has
developed tachyphylaxis
because of
repeated exposure to the drug.
C. This patient has
developed
pharmacodynamic
tolerance,
which has increased the minimal
effective concentration
(MEC) needed for analgesic effect.
D.This patient has increased
hepatic enzyme
production as
a result of prolonged exposure to
the drug.
The CNP realizes that beta1 C. Increased myocardial contractility and heart rate
receptor stimulation leads
to which condition?
